Connect with us

Hi, what are you looking for?

If implemented, pooling procurement of essential drugs and products and expanding local pharmaceutical production on the continent is seen as a critical pathway to the prosperity of African citizens, thereby achieving universal healthcare in Africa/FILE


US drugmaker Perrigo buys Irish Elan for $8.6 bn

US drugs company Perrigo said on July 29, 2013 it has agreed to buy Irish biotech firm Elan in an $8.6 bn deal/AFP

US drugs company Perrigo said on July 29, 2013 it has agreed to buy Irish biotech firm Elan in an $8.6 bn deal/AFP

DUBLIN, July 29 – US drugs company Perrigo is buying Irish biotech firm Elan for $8.6 billion (6.5 billion euros) in cash and shares, the firms said on Monday.

The deal is aimed at creating a global group with the strength to pursue expansion, and a new holding company will be based in Ireland.

The terms represents a 10.5 percent premium on Elan’s closing stock price on Friday.

Elan had put itself up for sale in June, when it rejected a takeover from US intellectual property investor Royalty Pharma worth as much up to $8.0 billion.

After completion of the deal, Perrigo shareholders will own 71 percent of the combined company, while Elan investors will own about 29 percent.

“Perrigo Company and Elan Corporation today announced that Perrigo and Elan have entered into a definitive agreement under which Elan will be acquired by a new holding company incorporated in Ireland (New Perrigo),” the firms said in a statement.

“The cash and stock transaction, which is valued at approximately US$8.6 billion will create a global healthcare company with an industry leading growth profile and the geographic scale and scope to continue building a truly differentiated business.”

Elan shareholders will receive $6.25 in cash and 0.07636 shares of New Perrigo for each Elan share, in a deal which values each Elan share at $16.50.

“Through this transaction, Perrigo establishes a diversified platform for further international expansion,” said Perrigo Chairman and CEO, Joseph C. Papa, in the statement.

“We believe this transaction is compelling for Elan shareholders and fully takes into account the value of Elan’s assets.”

Advertisement. Scroll to continue reading.

He added: “We believe the combination of Perrigo and Elan will create an industry leading global healthcare company with the balance sheet liquidity and operational structure to accelerate our growth and capitalize on international market opportunities.”

The transaction is expected to be completed by the end of the year.

Click to comment

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Ask Kirubi

It is without a doubt that the COVID-19 pandemic has caught the whole world by surprise. Although its full impact is yet to be...


NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...


NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...


NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...


NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...